Clinical Trial Update: Anti-inflammatory Efficacy for Prophylaxis of Cystoid Macular Edema (CME) After Phacoemulsification [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating anti-inflammatory efficacy for prophylaxis of cystoid macular edema after cataract surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract
• Cystoid Macular Edema

Snippet

Sponsor: Hospital Oftalmologico de Brasilia | Conditions: Cystoid Macular Edema, Cataract | Phase 4 | Status: COMPLETED